Education
About Us
Working with TipRanks
Follow Us
Jeffrey Rowe Insider Profile
4 Followers
Jeffrey Rowe, EVP Operations, Director at Diplomat Pharmacy, holds 12.24M shares in Zomedica (Ticker: ZOMDF), holds 1.71M shares in Diplomat Pharmacy (Ticker: DPLO).
Jeffrey Rowe Diplomat Pharmacy (DPLO)EVP Operations, Director
Diplomat Pharmacy (DPLO)
EVP Operations, Director
Ranked #78,835 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-27.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Jeffrey Rowe holds in companies
Most Profitable Insider Trade
Stock:
Diplomat Pharmacy
(DPLO)
(DPLO)
Rating:Informative Sell
Date:Mar 27, 2015 - Mar 27, 2016
Return:+21.20%
The most profitable trade made by Jeffrey Rowe
Jeffrey Rowe's Trading History
Diplomat Pharmacy
Mar 27, 2015
―
Informative Sell
17.40M
$6.83M
Zomedica
Dec 03, 2018
Director
Uninformative Buy
210.00K
$367.21K
List of latest transactions for each holding click on a transaction to see Jeffrey Rowe's performance on stock
You May Also Like
Jeffrey Rowe insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Rowe?
The percentage of profitable transactions made by Jeffrey Rowe is 33%.
What is the average return per transaction made by Jeffrey Rowe?
The average return per transaction made by Jeffrey Rowe is -27.40%.
What stocks does Jeffrey Rowe hold?
Jeffrey Rowe holds: DPLO, ZOMDF stocks.
What was Jeffrey Rowe’s latest transaction?
Jeffrey Rowe latest transaction was an Uninformative Buy of $210.00K.
What was Jeffrey Rowe's most profitable transaction?
Jeffrey Rowe’s most profitable transaction was an Informative Sell of DPLO stock on March 27, 2015. The return on the trade was 21.20%.
What is Jeffrey Rowe's role in Diplomat Pharmacy?
Jeffrey Rowe's role in Diplomat Pharmacy is EVP Operations, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.